Search research articles
Contact Us
Filters
Showing results (1-10 of 69) with videos related to
Page
of 7
Sort By:
Medicinski Arhiv
|
June 3, 2010
Gender differences in acute coronary syndrome in Serbia before organized primary PCI network service
Mirjana Krotin, Zorana Vasiljevic, Marija Zdravkovic, et al.
Current Pharmaceutical Design
|
July 12, 2018
Coronary Microcirculation in Heart Failure with Preserved Systolic Function
Zorana Vasiljevic, Gordana Krljanac, Marija Zdravkovic, et al.
Acta Cardiologica Sinica
|
June 9, 2016
Psychosocial Stress and Risk of Myocardial Infarction: A Case-Control Study in Belgrade (Serbia)
Isidora Vujcic, Hristina Vlajinac, Eleonora Dubljanin, et al.
Cardiology
|
September 2, 2006
Outcome of patients in relation to duration of new-onset atrial fibrillation following acute myocardial infarction
Milika Asanin, Zorana Vasiljevic, Mihailo Matic, et al.
Peptides
|
July 6, 2010
B-type natriuretic peptide in outpatients after myocardial infarction: optimized cut-off value for incident heart failure prediction
Mina Radovanovic, Zorana Vasiljevic, Nebojsa Radovanovic, et al.
The Journal of Invasive Cardiology
|
July 7, 2010
Prognostic significance of the occurrence of acute heart failure after successful primary percutaneous coronary intervention
Lidija Savic, Igor Mrdovic, Jovan Perunicic, et al.
Journal of Interventional Cardiology
|
November 23, 2011
Impact of the combined left ventricular systolic and renal dysfunction on one-year outcomes after primary percutaneous coronary intervention
Lidija Savic, Igor Mrdovic, Jovan Perunicic, et al.
Current Pharmaceutical Design
|
October 4, 2024
Homocysteine Blood Levels and Mandatory Folic Acid Fortification in Serbia
Zorana Vasiljevic, Natasa Zlatic, Dubravka Rajic, et al.
Journal of Interventional Cardiology
|
June 12, 2009
Development and validation of a risk scoring model to predict net adverse cardiovascular outcomes after primary percutaneous coronary intervention in patients pretreated with 600 mg clopidogrel: rationale and design of the RISK-PCI study
Igor Mrdovic, Lidija Savic, Jovan Perunicic, et al.
The Lancet Regional Health. Europe
|
November 13, 2023
Clinical determinants of ischemic heart disease in Eastern Europe
Edina Cenko, Olivia Manfrini, Natalia Fabin, et al.
Page
of 7
Search research articles
Search
Showing results (1-10 of 69) with videos related to
Sort By:
Page
of 7
Medicinski Arhiv
|
June 3, 2010
Gender differences in acute coronary syndrome in Serbia before organized primary PCI network service
Mirjana Krotin, Zorana Vasiljevic, Marija Zdravkovic, et al.
Current Pharmaceutical Design
|
July 12, 2018
Coronary Microcirculation in Heart Failure with Preserved Systolic Function
Zorana Vasiljevic, Gordana Krljanac, Marija Zdravkovic, et al.
Acta Cardiologica Sinica
|
June 9, 2016
Psychosocial Stress and Risk of Myocardial Infarction: A Case-Control Study in Belgrade (Serbia)
Isidora Vujcic, Hristina Vlajinac, Eleonora Dubljanin, et al.
Cardiology
|
September 2, 2006
Outcome of patients in relation to duration of new-onset atrial fibrillation following acute myocardial infarction
Milika Asanin, Zorana Vasiljevic, Mihailo Matic, et al.
Peptides
|
July 6, 2010
B-type natriuretic peptide in outpatients after myocardial infarction: optimized cut-off value for incident heart failure prediction
Mina Radovanovic, Zorana Vasiljevic, Nebojsa Radovanovic, et al.
The Journal of Invasive Cardiology
|
July 7, 2010
Prognostic significance of the occurrence of acute heart failure after successful primary percutaneous coronary intervention
Lidija Savic, Igor Mrdovic, Jovan Perunicic, et al.
Journal of Interventional Cardiology
|
November 23, 2011
Impact of the combined left ventricular systolic and renal dysfunction on one-year outcomes after primary percutaneous coronary intervention
Lidija Savic, Igor Mrdovic, Jovan Perunicic, et al.
Current Pharmaceutical Design
|
October 4, 2024
Homocysteine Blood Levels and Mandatory Folic Acid Fortification in Serbia
Zorana Vasiljevic, Natasa Zlatic, Dubravka Rajic, et al.
Journal of Interventional Cardiology
|
June 12, 2009
Development and validation of a risk scoring model to predict net adverse cardiovascular outcomes after primary percutaneous coronary intervention in patients pretreated with 600 mg clopidogrel: rationale and design of the RISK-PCI study
Igor Mrdovic, Lidija Savic, Jovan Perunicic, et al.
The Lancet Regional Health. Europe
|
November 13, 2023
Clinical determinants of ischemic heart disease in Eastern Europe
Edina Cenko, Olivia Manfrini, Natalia Fabin, et al.
Page
of 7